Rize Oncology Inc.
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -247.60K | -232.50K | -215.00K | -370.00K | -400.90K |
| Total Depreciation and Amortization | -- | 38.50K | 261.00K | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.10K | 9.00K | 46.70K | 3.50K | 17.60K |
| Change in Net Operating Assets | 180.00K | -97.60K | -105.70K | 69.80K | 700.00 |
| Cash from Operations | -49.50K | -282.50K | -13.10K | -296.70K | -382.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -150.00K | -- | -- |
| Cash from Investing | -- | -- | -150.00K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 357.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 47.40K | -- | -- | -- | -- |
| Cash from Financing | 47.40K | -- | 357.00K | -- | -- |
| Foreign Exchange rate Adjustments | -10.80K | 2.20K | 700.00 | 11.10K | 42.50K |
| Miscellaneous Cash Flow Adjustments | 11.10K | -- | 0.00 | -22.90K | -- |
| Net Change in Cash | -1.70K | -280.40K | 194.60K | -308.50K | -340.10K |